Steven Cohen’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.71M | Sell |
126,281
-68,868
| -35% | -$1.11M | ﹤0.01% | 2499 |
|
|
2026
Q2 | $4M | Sell |
195,149
-414,122
| -68% | -$9.48M | ﹤0.01% | 1914 |
|
|
2026
Q1 | $13.4M | Buy |
609,271
+492,840
| +423% | +$8.58M | 0.02% | 1046 |
|
|
2025
Q4 | $1.37M | Sell |
116,431
-902,105
| -89% | -$11.6M | ﹤0.01% | 2699 |
|
|
2025
Q3 | $16.1M | Buy |
1,018,536
+686,874
| +207% | +$10M | 0.03% | 631 |
|
|
2025
Q2 | $3.8M | Buy |
+331,662
| New | +$3.74M | 0.01% | 1058 |
|
|
2025
Q1 | – | Sell |
-334,070
| Closed | -$5.65M | – | 2086 |
|
|
2024
Q4 | $5.65M | Buy |
+334,070
| New | +$6.5M | 0.01% | 909 |
|
|
2024
Q3 | – | Sell |
-27,046
| Closed | -$553K | – | 2008 |
|
|
2024
Q2 | $610K | Sell |
27,046
-419,046
| -94% | -$11M | ﹤0.01% | 1390 |
|
|
2024
Q1 | $11.7M | Buy |
446,092
+131,792
| +42% | +$3.75M | 0.03% | 659 |
|
|
2023
Q4 | $9.9M | Buy |
+314,300
| New | +$8.53M | 0.02% | 693 |
|
|
2021
Q4 | – | Sell |
-17,500
| Closed | -$509K | – | 1112 |
|
|
2021
Q3 | $509K | Buy |
+17,500
| New | +$567K | ﹤0.01% | 920 |
|
|
2020
Q3 | – | Sell |
-708,299
| Closed | -$10.9M | – | 934 |
|
|
2020
Q2 | $10.9M | Buy |
708,299
+614,999
| +659% | +$7.78M | 0.07% | 317 |
|
|
2020
Q1 | $828K | Buy |
+93,300
| New | +$1.35M | 0.01% | 618 |
|
|
2019
Q4 | – | Sell |
-357,937
| Closed | -$5.35M | – | 982 |
|
|
2019
Q3 | $5.35M | Buy |
357,937
+230,937
| +182% | +$3.76M | 0.03% | 444 |
|
|
2019
Q2 | $3.05M | Sell |
127,000
-214,911
| -63% | -$6.33M | 0.02% | 595 |
|
|
2019
Q1 | $12.7M | Buy |
+341,911
| New | +$12.4M | 0.06% | 349 |
|
|
2018
Q4 | – | Sell |
-219,971
| Closed | -$8.68M | – | 980 |
|
|
2018
Q3 | $8.68M | Buy |
219,971
+160,471
| +270% | +$7.02M | 0.04% | 489 |
|
|
2018
Q2 | $2.64M | Sell |
59,500
-1,574,384
| -96% | -$78.3M | 0.01% | 723 |
|
|
2018
Q1 | $79.6M | Buy |
1,633,884
+989,926
| +154% | +$49.5M | 0.33% | 76 |
|
|
2017
Q4 | $32.2M | Buy |
643,958
+578,258
| +880% | +$30.3M | 0.14% | 197 |
|
|
2017
Q3 | $3.32M | Buy |
+65,700
| New | +$3.1M | 0.01% | 607 |
|
|
2017
Q2 | – | Sell |
-831,405
| Closed | -$32M | – | 843 |
|
|
2017
Q1 | $32M | Buy |
+831,405
| New | +$25M | 0.18% | 154 |
|
|
2016
Q4 | – | Sell |
-264,000
| Closed | -$4.22M | – | 710 |
|
|
2016
Q3 | $4.22M | Buy |
+264,000
| New | +$3.02M | 0.03% | 449 |
|
Other funds holding CC
CCPM
Steven Cohen's CC Position: Q3 2026 in Review
Steven Cohen reduced its Chemours (CC) stake by 35% in Q3 2026, selling an estimated $1.11M and leaving 126,281 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2499.
Steven Cohen first reported a position in CC in Q3 2016 and has held it in 23 quarters since. The position peaked at $79.6M in Q1 2018. 445 funds tracked by Wall St. Rank hold CC as of Q3 2026.
- Steven Cohen held 126,281 shares of Chemours worth $1.71M as of Q3 2026.
- Steven Cohen sold 68,868 Chemours shares in Q3 2026, an estimated $1.11M.
- Chemours made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2499 holding.
- Steven Cohen first reported a position in Chemours in Q3 2016 and has held it in 23 quarters since.
- Steven Cohen's Chemours position peaked at $79.6M in Q1 2018.
- 445 funds tracked by Wall St. Rank held Chemours as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.